Author: biocytogen

Peptalk 2020: The Protein Science Week

January 13, 2020

Location: Hilton San Diego Bayfront, San Diego, CA Dates: January 20-24, 2020 Booth: #424 RenMab™ Mouse: a leading platform for fully human antibody generation Speaker: Benny Yang, Chief Scientific Officer & Director of Antibody Discovery of Biocytogen Time: January 22 at 12:15 pm Track: Lead and Candidate Selection for Therapeutic Proteins Presentation Abstract: Biocytogen has […]

Read More

Nature Research Webcast: Accelerating therapeutic antibody discovery with fully human antibody mice

November 26, 2019

Date: December 10, 2019 Time: 8am PST / 11am EST / 4pm GMT / 5pm CET Register Now Overview: Production of fully human antibody is a critical step in the antibody discovery process. In many cases, hybridoma with genetically modified animals or post-optimization humanization are often employed to generate humanized antibodies. Amid the laborious procedures, some major […]

Read More

The Utility of the Rosa26 Knock-in Mouse

November 19, 2019

The Rosa26 locus in the mouse genome is a “safe harbor” which allows researchers to express genes of interest. Different gene targeting technologies (embryonic stem cells; CRISPR) are used to make specific DNA insertions at the Rosa26 locus. The rationale for scientists to use Rosa26 and other key benefits to using this type of mouse […]

Read More

PEGS Europe 2019

Date: November 18-22, 2019
Location: Lisbon Congress Center, Lisbon, Portugal

Location: Lisbon Congress Center, Lisbon, Portugal Dates: November 18-22, 2019 Booth: #349 RenMab™ Mouse: a leading platform for fully human antibody generation Speaker: Chaoshe Guo, Ph.D., M.D., Vice President & Global Head of Business Development of Biocytogen Time: November 20th, 10:05 – 10:35 Session: Advancing Bispecifics and Combination Therapy to the Clinic Presentation Abstract: Biocytogen […]

Read More

RenMab™ Mouse Featured in GEN Magazine

November 8, 2019

Biocytogen’s RenMab™ Mouse is featured in the Nov. Issue of Genetic Engineering & Biotechnology News (GEN). Read the full article here.  RenMab™ Mouse highlights: Developed upon Biocytogen’s unique Mb-scale chromosome engineering technology Variable regions of heavy chain and k light chain are replaced by human counterparts in situ Constant region is retained to ensure proper B […]

Read More

Biocytogen’s RenMab™ Mouse is Featured on Fiercebiotech

October 28, 2019

Biocytogen’s RenMab™ Mouse is featured on Fiercebiotech.com today. Read the full article here.  RenMab™ Mouse highlights: Developed upon Biocytogen’s unique Mb-scale chromosome engineering technology Variable regions of heavy chain and k light chain are replaced by human counterparts in situ Constant region is retained to ensure proper B cell development Normal response to immunization FierceBiotech and […]

Read More

Festival of Biologics 2019

October 7, 2019

Location: Basel Congress Centre, Basel, Switzerland Dates: October 15-17, 2019 Booth: 27 Presentation Title: Accelerating Therapeutic Antibody Discovery with Fully Human Antibody (RenMab™) Mice and Target Humanized Animal Models Speaker: Gary Ng, Marketing Manager, Biocytogen Time: Wednesday, October 16th, 3:15 – 3:35pm Presentation Session: Bispecifics development Presentation Abstract: Biocytogen has recently developed RenMab™ Mouse, a […]

Read More

Novel Antibody Therapeutics Congress

October 7, 2019

Location: London Heathrow Marriott Hotel, Bath Road, Harlington, Hayes, United Kingdom Dates: October 10-11, 2019 Booth: Ex-24 Presentation Title: Accelerating Therapeutic Antibody Discovery with Fully Human Antibody (RenMab™) Mice and Target Humanized Animal Models Speaker: Benny Yang, Ph.D., Chief Scientific Officer & Director of Antibody Discovery, Biocytogen Time: Thursday, October 10th, 10:20-10:50am Presentation Abstract: Biocytogen […]

Read More

2nd Annual Advances in Immuno-Oncology USA Congress

October 2, 2019

Location: DoubleTree by Hilton Hotel San Diego, Mission Valley, USA Dates: October 8-9, 2019 Booth: #4 Presentation Title: Accelerating Therapeutic Antibody Discovery with Fully Human Antibody (RenMab™) Mice and Target Humanized Animal Models Speaker: Chaoshe Guo, Ph.D., M.D., Vice President & Global Head of Business Development of Biocytogen Time: Tuesday, Oct. 8th, 1:50-2:20pm Session: Translational […]

Read More

Experts in Genetically Engineered Animal Development and Maintenance

September 11, 2019

Time: 10:30-11:30am, Sept. 19th, 2019 Location: Conference Room D1, Building 114, Massachusetts General Hospital, 16th Street, Charlestown MA  02129 Speakers: Daniel Trombly, Ph.D. Gene Editing Specialist, Biocytogen Boston Corporation Christopher Dowdy, Ph.D. Client & Scientific Portfolio Manager Research Models and Services, Charles River Laboratories

Read More

Back to top